Pharmaceutical Serialization : A Challenge for Small Manufacturers
DOI:
https://doi.org/10.32628/CSEIT228428Keywords:
Drug Traceability, Pharmaceutical Serialization, Small Pharmaceutical Business, Technical Infrastructure, Digital Drug Traceability, Track and Trace System, EPCIS, Covid-19 Economic Impact, Customized Traceability System, Labelling System for Drug Serialization, DSCSA.Abstract
The purpose of this paper is to focus on the Challenges faced by Small Manufacturers due to the Serialization compliance. Pharmaceutical serialization is the process of assigning unique serial number to each saleable product pack. Each product pack contains information about product source, Global Trade Identification Number (GTIN), Batch number, Expiry date and unique serial number. Pharmaceutical serialization is not new compliance, and it was initially introduced by Turkey in 2010, and other market such as the China and South Korea. Since many years China made compulsory for all supply chain partners to record drug distribution information of individuals drugs units in a traceability system. As we are approaching to 2023, It will be final phase of 10 yearlong implementation of Drug Supply Chain Security Act (DSCSA) since compliance enacted in 2013. Verification router services (Saleable Return) is another compliance which was scheduled to enforce on 2020 but it is now push back to 2023 due to Covid-19 impact. Under 2023 DSCSA Act, manufacturers need to provide product tracing information in secure and interoperable manner electronically to distributors and wholesaler in supply chain. Wholesaler must transfer product tracing information to dispensers and pharmacy and verify saleable returns receive from supply chain stakeholders. Dispenser/Pharmacy should be able to receive Electronic Product Code Information Services (EPCIS) and product tracing information electronically and to be able to reconcile physical product unique identifier with electronic records. Finally, everyone in supply chain must be connected electronically through interoperable network which will allow regulatory bodies to track and trace the information’s. The importance of drug traceability has been increasingly emphasized and mandated by several countries across the world. The Drug Supply Chain Security Act (DSCSA) has been working on a pilot project with big pharmaceutical companies, wholesalers and distributors to design and test interoperable network to trace pharmaceutical prescribed drug electronically at package level. This will help supply chain stakeholders to verify the authenticity of drug in United States.
References
- Sarkar, S. (2022). Challenges for Implementing Digital Drug Traceability in Developing Countries. International Journal of Research Publications, 103(1), 760–766. https://doi.org/10.47119/IJRP1001031620223477
- Traceability of counterfeit drugs in pharma supply chain http://eprints.manipal.edu/158678/1/DisplayPdf.aspx%20%281%29.pdf
- https://www.who.int/news/item/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified
- Vogt, T., & Serebrov, M. Global Tracking Regulations Present Challenges and Benefits
- Sarkar, S. (2022). Online Drug Trade – A threat to Pharmaceutical Industry. International Journal of Advance Research in Computer Science and Management, 10(5), 15-20. http://ijarcsms.com/docs/paper/volume10/issue5/V10I5-0021.pdf
- Arden, N. S., Fisher, A. C., Tyner, K., Yu, L. X., Lee, S. L., & Kopcha, M. (2021). Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future. International Journal of Pharmaceutics, 602, 120554. https://doi.org/10.1016/J.IJPHARM.2021.120554
- 2021). Smart pharmaceutical manufacturing: Ensuring end-to-end traceability and data integrity in medicine production. Big Data Research, 24, 100172.
- Sarkis, M.; Bernardi, A.; Shah, N.; Papathanasiou, M.M. Emerging Challenges and Opportunities in Pharmaceutical Manufacturing and Distribution. Processes 2021, 9, 457. https:// doi.org/10.3390/pr9030457
- Sarkar, S. (2022). Supply Chain Security Act 2023 : Interoperable Data Exchange for Drug Traceability. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 8(3), 471-476. https://doi.org/10.32628/CSEIT228390
- Hole, G., Hole, A. S., & McFalone-Shaw, I. (2021). Digitalization in pharmaceutical industry: What to focus on under the digital implementation process? International Journal of Pharmaceutics: X, 3, 100095. https://doi.org/10.1016/J.IJPX.2021.100095
- Rault-Chodankar, Y. M., & Kale, D. (2022). ‘Manufacturers without factories’ and economic development in the Global South: India’ pharmaceutical firms. Journal of Economic Geography. https://doi.org/10.1093/jeg/lbac013
- Chitra, M., and Nandan Kumar. “Pharmaceutical Market Structure in India & Competition Concerns.” Shanlax International Journal of Arts, Science and Humanities, vol. 8, no. 1, 2020, pp. 233–241. https://doi.org/10.34293/ sijash.v8i1.3295
- Sarkar, S. (2022). Pharmaceutical serialization: Impact on drug packaging. International Journal of Advance Research in Computer Science and Management Studies, 10(3), 21-26. http://www.ijarcsms.com/docs/paper/volume10/issue3/V10I3-0034.pdf
- https://www.tracelink.com/knowledge-base/how-much-will-serialization-really-cost
- Gupta, P., Hudnurkar, M., & Ambekar, S. (2021). Effectiveness of blockchain to solve the interoperability challenges in healthcare. Cardiometry, (20), 79-87.
- Le, P., Grund, L., Marwa, J., Ojo, W., Otts Jr, J., & Arab, F. (2018). Combating Substandard and Counterfeit Medicines by Securing the Pharmaceutical Supply Chain: The Drug Supply Chain Security Act (DSCSA) of 2013. Innovations in Pharmacy, 9(2), 1.
- Shanley, A. (2018). Serialization: Scaling Down for the Final Stretch. PharmTech. com, 38.
- Sarkar, S. (2022). Digital Traceability of pharmaceutical drug in supply chain. International Journal of Advance Research in Computer Science and Management, 10(2), 39-44. http://ijarcsms.com/docs/paper/volume10/issue2/V10I2-0037.pdf
Downloads
Published
Issue
Section
License
Copyright (c) IJSRCSEIT

This work is licensed under a Creative Commons Attribution 4.0 International License.